María Garcés‐Sánchez

Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial

Peter Richmond, Helen Marshall, Michael D. Nissen et al. · The Lancet Infectious Diseases · 2012 · 131 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +12

Clinical and economic burden of respiratory syncytial virus in Spanish children: the BARI study

Federico Martinón‐Torres, Mafalda Carmo, L. Platero et al. · BMC Infectious Diseases · 2022 · 80 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Immunogenicity and Safety of H5N1 A/Vietnam/1194/2004 (Clade 1) AS03-Adjuvanted Prepandemic Candidate Influenza Vaccines in Children Aged 3 to 9 Years

Javier Díez‐Domingo, María Garcés‐Sánchez, José‐María Baldó et al. · The Pediatric Infectious Disease Journal · 2010 · 76 citations · Full text

Medicine, Immunology, Pediatrics +17

Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086: 4 year follow-up of a randomised, single-blind, placebo-controlled, phase 2 trial

Helen Marshall, Peter Richmond, Johannes Beeslaar et al. · The Lancet Infectious Diseases · 2016 · 39 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Factors influencing HPV knowledge and vaccine acceptability in parents of adolescent children: results from a survey-based study (KAPPAS study)

Noelia López, Ignacio Salamanca de la Cueva, Edelmiro Vergés et al. · Human Vaccines & Immunotherapeutics · 2022 · 38 citations · Full text

Medicine, Child Health, Pediatrics +14